DNA RNA and Cells

13 Mar 2008 Arrowhead Subsidiary, Calando Pharmaceuticals, Submits IND for Clinical Trial with Targeted, Nano-Delivered RNAi Therapeutic for Cancer
12 Mar 2008 Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products
12 Mar 2008 Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug
11 Mar 2008 Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
06 Mar 2008 Oncolys BioPharma and Medigen Biotechnology Enters Strategic Alliance and License Agreement to Develop and Commercialize Telomelysin(R)(OBP-301) for a Potential New Treatment for Solid Tumors
04 Mar 2008 Pluristem Submits Pre-IND Application in Germany to Initiate Clinical Trials of PLX-PAD for Peripheral Artery Disease
29 Feb 2008 Phase II Clinical Trial of ALN-RSV01 Demonstrates Statistically Significant Anti-Viral Efficacy with an Approximately 40% Reduction in RSV Infection Rate and 95% Increase in Infection-Free Subjects
28 Feb 2008 AVONTEC announce results of a multiple dose clinical proof of concept study with its drug candidate AVT-01 decoy ODN in asthmatic patients
26 Feb 2008 Prochymal(TM) Demonstrates Lasting Benefit in Heart Attack
25 Feb 2008 Harvest Technologies announces patient enrollment has begun for a clinical trial in India using autologous adult stem cells to treat patients with non-reconstructible Critical Limb Ischemia (CLI) due to Peripheral Arterial Occlusive Disease (PAOD)
15 Feb 2008 OncoGenex Reports Lead Drug Candidate OGX-011 Achieved Primary Endpoint in Phase 2 Trial with Second-Line Chemotherapy for Prostate Cancer
14 Feb 2008 Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
13 Feb 2008 Introgen's p53 Immunotherapy INGN 225 Begins Randomized, Controlled Clinical Trial in Patients with Small Cell Lung Cancer
13 Feb 2008 Ophthotech Enrolls Its First Patient in a Phase I Anti-PDGF Macular Degeneration Trial
09 Feb 2008 VGX Pharmaceuticals Announces the IND Filing of VGX-3200, a Novel DNA Therapy That Utilizes GHRH for the Treatment of Cancer Cachexia and Anemia
07 Feb 2008 Alnylam Reports Pre-clinical Progress with RNAi Therapeutics in Neurological Disease
06 Feb 2008 Insception Biosciences Begins Human Clinical Trials of Stem Cell Treatment That Could Replace Bone Marrow Transplants
30 Jan 2008 Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
29 Jan 2008 Topigen Pharmaceuticals Initiates European Phase 2 Clinical Study of TPI ASM8 in Patients with Asthma
23 Jan 2008 Alnylam Reports Positive Phase II Data for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
22 Jan 2008 MolMed gets regulatory approval to start a Phase III trial in Italy of its TK therapy for high risk acute leukaemia
18 Jan 2008 StemCells, Inc. Provides Batten's Clinical Trial Update
18 Jan 2008 Clinical Trial to Treat Rare Skin Disorder With siRNA Technology
11 Jan 2008 Transgene's Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer
08 Jan 2008 Sangamo BioSciences Initiates Phase 2 Clinical Trial of ZFP Therapeutic in Stem Cell Mobilization

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top